Zhang Y - Search Results

1

Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI.

Yang B, Luo C, Yu M, Zhou L, Tao B, Tang B, Zhou Y, Zhu J, Huang M, Peng F, Liu Y, Xu Y, Zhang Y, Zhou X, Xue J, Li Y, Wang Y, Li Z, Lu Y, Lui S, Gong Y. Yang B, et al. Among authors: zhang y. Front Oncol. 2021 Jan 6;10:573512. doi: 10.3389/fonc.2020.573512. eCollection 2020. Front Oncol. 2021. PMID: 33489880 Free PMC article.

2

Malignant Pleural Effusion and ascites Induce Epithelial-Mesenchymal Transition and Cancer Stem-like Cell Properties via the Vascular Endothelial Growth Factor (VEGF)/Phosphatidylinositol 3-Kinase (PI3K)/Akt/Mechanistic Target of Rapamycin (mTOR) Pathway.

Yin T, Wang G, He S, Shen G, Su C, Zhang Y, Wei X, Ye T, Li L, Yang S, Li D, Guo F, Mo Z, Wan Y, Ai P, Zhou X, Liu Y, Wang Y, Wei Y. Yin T, et al. Among authors: zhang y. J Biol Chem. 2016 Dec 23;291(52):26750-26761. doi: 10.1074/jbc.M116.753236. Epub 2016 Oct 18. J Biol Chem. 2016. PMID: 27756837 Free PMC article.

3

Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: A multicenter study and pooled analysis of published reports.

Liu Y, Zhang Y, Zhang L, Liu B, Wang Y, Zhou X, Li Y, Zhao Q, Gong Y, Zhou L, Zhu J, Ding Z, Wang J, Peng F, Huang M, Li L, Ren L, Lu Y. Liu Y, et al. Among authors: zhang l, zhang y. Oncotarget. 2017 Jul 25;8(30):49680-49688. doi: 10.18632/oncotarget.17915. Oncotarget. 2017. PMID: 28591695 Free PMC article.

4

Conventional real-time PCR-based detection of T790M using tumor tissue or blood in patients with EGFR TKI-resistant NSCLC.

Wu YL, Tong RZ, Zhang Y, Hu BB, Zheng K, Ding ZY, Peng F, Gong YL, Liu YM, Lu Y. Wu YL, et al. Among authors: zhang y. Onco Targets Ther. 2017 Jul 5;10:3307-3312. doi: 10.2147/OTT.S136823. eCollection 2017. Onco Targets Ther. 2017. PMID: 28740406 Free PMC article.

5

Reporting on Two Novel Fusions, DYSF-ALK and ITGAV-ALK, Coexisting in One Patient with Adenocarcinoma of Lung, Sensitive to Crizotinib.

Yin J, Zhang Y, Zhang Y, Peng F, Lu Y. Yin J, et al. Among authors: zhang y. J Thorac Oncol. 2018 Mar;13(3):e43-e45. doi: 10.1016/j.jtho.2017.10.025. J Thorac Oncol. 2018. PMID: 29472060 Free article. No abstract available.

6

Comparison of chemotherapy plus bevacizumab vs. chemotherapy alone as third-line treatment or beyond for advanced non-small cell lung cancer: A propensity score-matched analysis.

Hu B, Zhou X, Liu Y, Li Q, Xiang M, Zou B, Peng F, Huang M, Gong Y, Zhu J, Wang Y, Ren L, Xu Y, Zhang Y, Li Y, Yu M, Xue J, Deng L, Wang J, Ding Z, Lu Y. Hu B, et al. Among authors: zhang y. Oncol Lett. 2018 Apr;15(4):5671-5679. doi: 10.3892/ol.2018.8064. Epub 2018 Feb 15. Oncol Lett. 2018. PMID: 29556304 Free PMC article.

7

Leptomeningeal metastasis after effective first-generation EGFR TKI treatment of advanced non-small cell lung cancer.

Wu YL, Zhao Q, Deng L, Zhang Y, Zhou XJ, Li YY, Yu M, Zhou L, Zou BW, Lu Y, Liu YM. Wu YL, et al. Among authors: zhang y. Lung Cancer. 2019 Jan;127:1-5. doi: 10.1016/j.lungcan.2018.11.022. Epub 2018 Nov 20. Lung Cancer. 2019. PMID: 30642536

8

Pulmonary metastases of fibrosarcomatous dermatofibrosarcoma protuberans respond to apatinib-based angiogenesis and chemotherapy: a case report.

Chen H, Liu Y, Peng F, Huang J, Wen X, Ding Z, Zhang S, Zhang Y, Lu Y. Chen H, et al. Among authors: zhang s, zhang y. Ann Transl Med. 2019 Apr;7(7):149. doi: 10.21037/atm.2019.02.20. Ann Transl Med. 2019. PMID: 31157270 Free PMC article.

9

Significant benefits of osimertinib in treating acquired resistance to first-generation EGFR-TKIs in lung squamous cell cancer: A case report.

Zhang Y, Chen HM, Liu YM, Peng F, Yu M, Wang WY, Xu H, Wang YS, Lu Y. Zhang Y, et al. World J Clin Cases. 2019 May 26;7(10):1221-1229. doi: 10.12998/wjcc.v7.i10.1221. World J Clin Cases. 2019. PMID: 31183356 Free PMC article.

10

Discovery of the First Low Nanomolar Liver Receptor Homolog-1 (LRH-1) Agonist.

Wu X, Zhang Y, Xu Y. Wu X, et al. Among authors: zhang y. J Med Chem. 2019 Dec 26;62(24):11019-11021. doi: 10.1021/acs.jmedchem.9b01753. Epub 2019 Nov 21. J Med Chem. 2019. PMID: 31751137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261,524 results

Search Page

Filters